Interleukin-15 as an activator of natural killer cell-mediated antiviral response

Blood

Volumn 94, Issue 12, 1999, Pages 4210-4219

  Gosselin, Jean ^b   Tomol̈u, Andru ^b   Gallo, Robert C ^b   Flamand, Louis ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN SPECIFICITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0032762795     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4210.424k07_4210_4219     Document Type: Article

References (79)

1. Ching C, Lopez C: Natural killing of herpes simplex virus type 1-infected target cells: Normal human responses and influence of antiviral antibody. Infect Immun 26:49, 1979
2. Lopez C, Kirkpatrick D, Read SE, Fitzgerald PA, Pitt J, Pahwa S, Ching CY, Smithwick EM: Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections. J Infect Dis 147:1030, 1983
3. Fleisher G, Starr S, Koven N, Kamiya H, Douglas SD, Henle W: A non-x-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J Pediatr 100:727, 1982
4. Biron CA, Byron JCS, Sullivan JL: Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731, 1989
5. Joncas J, Monczak Y, Ghibu F, Alfieri C, Bonin A, Ahronheim G, Rivard G: Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J Med Virol 28:110, 1989
6. Merino F, Henle W, Ramirez-Duque P: Chronic active Epstein-Barr virus infection in patients with Chediak Higashi syndrome. J Clin Immunol 6:299, 1986
7. Quinnan GV Jr, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, Santos GW, Saral R, Burns WH: Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 307:7, 1982
8. Orange JS, Wang B, Terhorst C, Biron CA: Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182:1045, 1995
9. Welsh RM, Brubaker JO, Vargas-Cortes M, O'Donnell CL: Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J Exp Med 173:1053, 1991
10. Bukowski JF, Woda BA, Welsh RM: Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol 52:119, 1984
11. Herberman RB, Ortaldo JR: Natural killer cells: Their roles in defenses against disease. Science 214:24, 1981
12. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187, 1989
13. Santoli D, Trinchieri G, Koprowski H: Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J Immunol 121:532, 1978
14. Gidlund M, Orn A, Wigzell H, Senik A, Gresser I: Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759, 1978
15. Grundy JE, Trapman J, Allan JE, Shellam GR, Melief CJ: Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect Immun 37:143, 1982
16. Orange JS, Biron CA: An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156:1138, 1996
17. Biron CA, Orange JS: IL12 in acute viral infectious disease. Res Immunol 146:590, 1995
18. Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 154:483, 1995
19. Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA: The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4940, 1994
20. Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA: A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4935, 1994
21. Carson WE, Giri JG, Lindemann MJ, Linen ML, Ahdieh M, Paxton R, Anderson D. Eisenmann J, Grabstein K, Caligiuri MA: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395, 1994
22. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG: Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965, 1994
23. Khan IA, Kasper LH: IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. J Immunol 157:2103, 1996
24. Blauvelt A, Asada H, Klaus-Kovtun V, Altman DJ, Lucey DR, Katz SI: Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J Invest Dermatol 106:1047, 1996
25. Jonuleit H, Wiedemann K, Muller G, Degwert J, Hoppe U, Knop J, Enk AH: Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: A role for IL-15 in attraction of T cells. J Immunol 158:2610, 1997
26. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani N, Grabstein K. Caligiuri MA: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 96:2578, 1995
27. Doherty TM, Seder RA, Sher A: Induction and regulation of IL-15 expression in murine macrophages. J Immunol 156:735, 1996
28. Flamand L, Stefanescu I, Menezes J: Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 97:1373, 1996
29. Mohamadzadeh M, McGuire MJ, Dougherty I, Cruz PD Jr: Interleukin-15 expression by human endothelial cells: up-regulation by ultraviolet B and psoralen plus ultraviolet A treatment. Photodermatol Photoimmunol Photomed 12:17, 1996
30. + hematopoietic progenitor cells. Blood 87:2632, 1996
31. McInnes IB, al-Mughales J, Field M, Leung BP, Huang FP, Dixon R, Sturrock RD, Wilkinson PC, Liew FY: The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 2:175, 1996
32. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822, 1994
33. Kumaki S, Armitage R, Ahdieh M, Park L, Cosman D: Interleukin-15 up-regulates interleukin-2 receptor alpha chain but downregulates its own high-affinity binding sites on human T and B cells. Eur J Immunol 26:1235, 1996
34. Wilkinson PC, Liew FY: Chemoattraction of human blood T lymphocytes by interleukin-15. J Exp Med 181:1255, 1995
35. Flamand L, Gosselin J, D'Addario M, Hiscott J, Ablashi DV, Gallo RC, Menezes J: Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 65:5105, 1991
36. Miller G, Lipman M: Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190, 1973
37. Josephs SF, Ablashi DV, Salahuddin SZ, Jagodzinski LL, Wong-Staal F, Gallo RC: Identification of the human herpesvirus 6 glycoprotein H and putative large tegument protein genes. J Virol 65:5597, 1991
38. Gribaudo G, Ravaglia S, Caliendo A, Cavallo R, Gariglio M, Martinotti MG, Landolfo S: Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 197:303, 1993
39. Martinotti MG, Gariglio M, Cofano F, Cavallo G, Landolfo S: The role of interferons in the resistance to murine cytomegalovirus. Microbiologica 13:305, 1990
40. Martinotti MG, Gribaudo G, Gariglio M, Caliendo A, Lembo D, Angeretti A, Cavallo R, Landolfo S: Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. J Interferon Res 13:105, 1993
41. Schut RL, Gekker G, Hu S, Chao CC, Pomeroy C, Jordan MC, Peterson PK: Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma. J Infect Dis 169:1092, 1994
42. Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski UH: Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol 75:101, 1994
43. van der Meer JW, Rubin RH, Pasternack M, Medearis DN, Lynch P, Dinarello CA: The in vivo and in vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infection. Biotherapy 1:227, 1989
44. Scharton TM, Scott P: Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 178:567, 1993
45. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I: Immune responses in interleukin-2-deficient mice. Science 262:1059, 1993
46. Su HC, Orange JS, Fast LD, Chan AT, Simpson SJ, Terhorst C, Biron CA: IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. J Immunol 153:5674, 1994
47. Jullien D, Sieling PA, Uyemura K, Mar ND, Rea TH, Modlin RL: IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol 158:800, 1997
48. Nishimura H, Hiromatsu K, Kobayashi N, Grabstein KH, Paxton R, Sugamura K, Bluestone JA, Yoshikai Y: IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection J Immunol 156:663, 1996
49. Atedzoe BN, Ahmad A, Menezes J: Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J Immunol 159:4966, 1997
50. Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA: A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 99:937, 1997
51. Lucey DR, Pinto LA, Bethke FR, Rusnak J, Melcher GP, Hashemi FN, Landay AL, Kessler HA, Paxton RJ, Grabstein K, Shearer GM: In vitro immunologie and virologie effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 4:43, 1997
52. Yoshida A, Koide Y, Uchijima M, Yoshida TO: IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem Biophys Res Commun 198:857, 1994
53. Libraty DH, Airan LE, Uyemura K, Jullien D, Spellberg B, Rea TH, Modlin RL: Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy. J Clin Invest 99:336, 1997
54. Fantuzzi L, Gessani S, Borghi P, Varano B, Conti L, Puddu P, Belardelli F: Induction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 in human monocytes/macrophages: Requirement of gamma Interferon for IL-12 secretion. J Virol 70:4121, 1996
55. Hunter CA, Subauste CS, Van Cleave VH, Remington JS: Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: Regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 62:2818, 1994
56. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 90:6115, 1993
57. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of interferon gamma production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J Exp Med 173:869, 1991
58. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725, 1993
59. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387, 1992
60. Kanangat S, Thomas J, Gangappa S, Babu JS, Rouse BT: Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J Immunol 156:1110, 1996
61. Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F, Caligiuri MA: Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response. J Immunol 162:4511, 1999
62. Howell DM, Fitzgerald-Bocarsly P: Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells. Immunology 72: 443, 1991
63. Kaplan J, Shope TC: Natural killer cells inhibit outgrowth of autologous Epstein-Barr virus-infected B lymphocytes. Nat Immun Cell Growth Regul 4:40, 1985
64. Blazar B, Patarroyo M, Klein E, Klein G: Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate. J Exp Med 151:614, 1980
65. Blazar BA, Strome M, Schooley R: Interferon and natural killing of human lymphoma cell lines after induction of the Epstein Barr viral cycle by superinfection. J Immunol 132:816, 1984
66. Bishop GA, Glorioso JC, Schwartz SA: Relationship between expression of herpes simplex virus glycoproteins and susceptibility of target cells to human natural killer activity. J Exp Med 157:1544, 1983
67. Masucci MG, Bejarano MT, Masucci G, Klein E: Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells. Cell Immunol 76:311, 1983
68. Shope TC, Kaplan J: Inhibition of the in vitro outgrowth of Epstein-Barr virus-infected lymphocytes by TG lymphocytes. J Immunol 123:2150, 1979
69. Munoz A, Carrasco L, Fresno M: Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by Interferon. J Immunol 131:783, 1983
70. Fitzgerald PA, Mendelsohn M, Lopez C: Human natural killer cells limit replication of herpes simplex virus type 1 in vitro. J Immunol 134:2666, 1985
71. Yasukawa M, Kobayashi Y: Inhibition of herpes simplex virus replication in vitro by human cytotoxic T cell clones and natural killer cell clones. J Gen Virol 66:2225, 1985
72. Colmenares C, Lopez C: Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors. J Immunol 136:3473, 1986
73. Bishop GA, McCurry L, Schwartz SA, Glorioso JC: Activation of human natural killer cells by herpes simplex virus type 1-infected cells. Intervirology 28:78, 1987
74. Canessa A, Chatterjee S, Whitley RJ, Prasthofer EF, Grossi CE, Tilden AB: Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon. Viral Immunol 3:217, 1990
75. Lopez-Guerrero JA, Alarcon B, Fresno M: Mechanism of recognition of herpes simplex virus type 1-infected cells by natural killer cells. J Gen Virol 69:2859, 1988
76. Fitzgerald-Bocarsly P, Howell DM, Pettera L, Tehrani S, Lopez C: Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts. J Virol 65:3151, 1991
77. Malnati MS, Lusso P, Ciccone E, Moretta A, Moretta L, Long EO: Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J Exp Med 178:961, 1993
78. Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell S, Jackson R, Li Y, Romano JW, Fauci AS: Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 102:223, 1998
79. Fehniger TA, Herbein G, Yu H, Para MI, Bernstein ZP, O'Brien WA, Caligiuri MA: Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol 161:6433, 1998